PATENT CLAIM ANALYSIS

Application Number: 16029185
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["546", "208000"]

Abstract:
The present invention provides novel piperidinyl-containing nociceptin receptor ligand compounds and pharmaceutical compositions useful in the treatment of neurological diseases and conditions where such ligands mediate the negative effects of the condition. Such neurological diseases and conditions include acute and chronic pain, substance abuse/dependence, alcohol addiction, anxiety, depression, sleep disorders, gastrointestinal disorders, renal disorders, cardiovascular disorders and Parkinson's disease.

Claim (Index 5):
The compound of  claim 4 , wherein Z is alkyl, substituted alkyl, heteroalkyl or substituted heteroalkyl.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 95.0
- Lexical Diversity: 1.42857
- Patent Class: 546.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15368508', '11923507', '11242654', '14779191', '10656934']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8064617592105621
- 35 USC 102 Novelty (BERT): 0.6085188029230414
- Combined Prediction Score: 0.7866674635818101
- Mean Citation Score: 334.4602700000001
- Max Citation Score: 539.73456
- Similarity Product: 388.92616595438005

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test